Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53358

language	eng
Author	Kato Takayuki Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Honda Yasushi Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Kurita Yusuke Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Iwasaki Akito Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Sato Takamitsu Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Kessoku Takaomi Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Uchiyama Shiori Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Ogawa Yuji Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Ohkubo Hidenori Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Higurashi Takuma Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan Yamanaka Takeharu Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokoahama, Kanagawa, Japan Usuda, Haruki Wada, Koichiro Nakajima Atsushi Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
Journal Title	PLOS ONE
Volume	12
Issue	4
ISSN	1932-6203
Published Date	2017-04-14
DOI	10.1371/journal.pone.0175626
PubMed ID	28410406
Publisher	PUBLIC LIBRARY SCIENCE
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	This research was funded by a grant from Mylan EPD G.K. (Mylan EPD), which is the distributor of lubiprostone in Japan. There are no grant numbers. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.